-
Dr. Huibiao Zhang: Three Osimertinib Adjuvant Studies Shine at ELCC, Adding New Evidence for Early-Stage Lung Cancer Treatment
The European Lung Cancer Congress (ELCC) is one of the most anticipated academic conferences in the field of lung cancer, jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC). Since its inception in 2008, ELCC has become one of the premier conferences for…
-
“Recent Developments in Lung Cancer Research: Insights from ELCC 2023”
Dr Paz-Ares: I think this meeting is a particularly relevant meeting for continuous education, where the different and relevant aspects of lung cancer diagnosis, treatment and so on are reviewed and updated compared to standard-of-care. On top of that, some new data are typically presented. A good highlight for the current conference this year were…
-
Dr. P. Garrido Lopez Interprets Latest Data from CHRYSALIS
On the first day of the 2023 European Lung Cancer Congress (ELCC), during the oral presentation session, Dr. P. Garrido Lopez from Ramón y Cajal University Hospital in Madrid, Spain, presented the long-term efficacy, safety, and predictive factors of amivantamab in the treatment of platinum-treated EGFR exon 20 insertion (EGFR ex20ins) mutant advanced non-small cell…
-
ESMO Expert Commentary | Dr. Yao Zhu: Success or Failure Does Not Define a Hero, Numerous Prostate Cancer Studies Aid in Optimizing Patient Survival
Editor’s Note: Prostate cancer is the leading male urological tumor in China and has become one of the fastest-growing male malignancies in the past decade. The recent ESMO conference unveiled…
-
ESMO China Voice | Professor Bin Shao : Comprehensive Genomic Analysis of Advanced HR+/HER2- Breast Cancer Patients Using Liquid Biopsy
Editor’s Note: HR+/HER2- is the most common subtype of breast cancer, accounting for approximately 65% to 70% of all breast cancer cases. Improving the survival benefits for patients with advanced…
-
AASLD Voice of China| Dr. Song Yang’s Team: Survival Prediction in Chinese Alcohol- Related Liver Disease — Sarcopenia is an Independent Factor, MELD
Editor’s Note: From November 10th to 14th, the annual highlight event in the field of hepatology, the American Association for the Study of Liver Diseases (AASLD) 2023 Annual Meeting, took…
-
AASLD 2023 Highlights: Conference Overview and Special Topics Collection
Editor’s Note: From November 10th to 14th, the annual grand event in the field of hepatology, the American Association for the Study of Liver Diseases (AASLD) Annual Meeting 2023, is…
-
AASLD Hot Updates on MASLD from the 2023 Annual Meeting
Editor’s Note: On November 7, 2023, at 12:30 PM local time in Boston, the American Association for the Study of Liver Diseases (AASLD) held its sole pre-conference press briefing on…
Connecting Medical Expertise through Media